---  
layout: startup_page  
title: "858 Therapeutics"  
id: "8five8tx.com"  
permalink: "/858therapeutics8five8tx.com09262024/"  
website: "https://www.8five8tx.com/"  
funding_round: "Series B"  
funding_amount: "$50M"  
investors: "Avidity Partners, Insight Partners, Mirae Asset Capital, Alexandria Venture Investments, Versant Ventures, NEA, Logos Capital"  
about: "858 Therapeutics is a biotechnology and drug discovery company developing small molecule therapeutics targeting oncology and immunology. Their lead program, ETX-19477, is a PARG inhibitor currently in Phase 1 clinical trials for advanced solid tumors. The company leverages decades of drug discovery experience from its founders."  
markets: "Biotechnology, Oncology, Immunology, Drug Discovery"  
hq: "San Diego, California, United States"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/858-therapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/858-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/434291-86"  

date_display: "26-Sep-2024"  
date: "2024-09-26"

# SEO Optimization  
meta_title: "858 Therapeutics - Series B Funding ($50M)"  
meta_description: "858 Therapeutics, 858 Therapeutics is a biotechnology and drug discovery company developing small molecule therapeutics targeting oncology and immunology. Their lead pr..."  
meta_keywords: "858 Therapeutics, Biotechnology, Oncology, Immunology, Drug Discovery, Series B funding"  
canonical_url: "https://startup.projectstartups.com/858therapeutics8five8tx.com09262024/"  
---